Biopharma Pharma Pharmaceutical manufacturing 
Fierce Pharma
JULY 12, 2023
A new triumvirate of biopharma bigwigs is in line to reign over one of the industry’s top trade groups. | The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has unveiled the upcoming lineup for its CEO leadership team over the next two years.
pharmaphorum
DECEMBER 28, 2022
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 14, 2023
The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site. This increases renewable energy capacity to the national gas grid.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. What is driving adoption of quality management systems in pharma? billion by 2030.
European Pharmaceutical Review
SEPTEMBER 26, 2022
Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards.
Pharmaceutical Technology
SEPTEMBER 13, 2022
The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product. The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise.
PM360
SEPTEMBER 30, 2024
Sustainable Tech’s Positive Effect on Pharma Funding Recent innovations, including rapid advancements in AI-powered technologies and GLP-1s, have significantly impacted the investment climate and consolidated funding to a smaller number of organizations in the last eight months.
Expert insights. Personalized for you.
177 
Let's personalize your content